Asparlas Injection, Solution
Product Images NDC 72694-515

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Asparlas (NDC 72694-515). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Servier Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (5 mL Vial Carton)

This is a description of "ASPARLAS™" injection, a medication used for intravenous infusion. Each vial contains 3750 units of calaspargase pegol-mknl with a concentration of 750 units/mL, to be diluted before use. The usual dosage instructions can be found in the prescribing information. The medication is produced by Servier Pharmaceuticals LLC and contains dibasic sodium phosphate, monobasic sodium phosphate, and sodium chloride in water for injection, USP. The medication is stored in a refrigerated environment between 2°C and 8°C, away from light, and should not be frozen or shaken. The GTIN and SN numbers are provided, as well as the NDC numbers.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.